Texas A&M Science -- Fighting Fibrosis (VIDEO) Texas A&M University This video is under embargo. Please login to access this video. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Caption A decade after first identifying serum amyloid P (SAP) as a key protein in human blood that controls routine tissue-related processes from scarring to healing, Texas A&M biologists Richard Gomer and Darrell Pilling and the biotechnology company they co-founded, Promedior Inc., continue to make encouraging progress in the fight against fibrotic disease, a broad class of chronic conditions associated with an estimated 45 percent of US deaths per year. Learn more about their work at http://tx.ag/FightingFibrosis. Credit Texas A&M College of Science Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.